Evaluating RELiZORB Use for the Treatment of Feeding Intolerance in Adults With Moderate to Severe Acute Pancreatitis

The goal of this study is to learn if Relizorb, a fat-digesting enzyme, can improve tolerance of tube feeds in adult patients with moderate to severe pancreatitis. The main question it aims to answer is: Does Relizorb allow more nutrition to be delivered to participants than they received without it? Participants will be observed with standard, universal monitoring after adding Relizorb to their nutrition regimen.

NCT Number	NCT07583342
Lead Sponsor	Northwell Health Collaborators: Alcresta Therapeutics, Inc.
Conditions	Acute Pancreatitis (AP), Enhancing Enteral Nutrition Tolerance
Enrollment	15 participants
Start Date	2025-12-08
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-13